Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Aug 29;47:329–340. doi: 10.1016/j.ebiom.2019.08.045

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 Published by Elsevier B.V.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

PMC Copyright notice

Fig. 3 — cTnImAbs as bioactive alternative for cTnIAAb.

a. Differential binding affinities of cTnImAb1, −2, and −3 for myocardial membrane as revealed by flow cytometry. cTnImAb1 exhibited the highest binding force.

b & c. Flow cytometry showed that cTnImAb1 was a potent competitor against human cTnIAAb in binding to the myocardial cell membrane. Shown are representative images (b) and quantification (c). *p = .000 (ANOVA analysis).

d. Differential binding affinities of cTnImAb1, −2 and −3 for the membranes of BCG823 cells as revealed by flow cytometry. cTnImAb1 exhibited the highest affinity.

e & f. Flow cytometry showed that cTnImAb1 was a potent competitor against human cTnIAAb in binding to the membrane of BCG823 cells. Shown are representative images (e) and quantification (f). *p = .000 (ANOVA analysis).